Huma Therapeutics Stock
Huma provides a digital health platform used for predictive care and research.
Sign up today and learn more about Huma Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Huma Therapeutics Stock
Huma is a global health technology company that provides a modular platform to support digital 'hospitals at home' across different disease areas. Its platform combines predictive algorithms, digital biomarkers, and real-world data to advance proactive, predictive care and research. The company was founded in 2011 and is headquartered in London, England.
Co-founder & CEO
Co-founder and Executive Director
SVP Business Development, US
Life Sciences Partnerships Manager
Product Design Lead
Head of Healthcare
Talent Partner - Technology and Product
Senior Vice President
Rt Hon Alan Milburn
TechCrunch - Apr, 16 2020Medopad rebrands as Huma, acquires BioBeats and TLT to expand its biomarker platform
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase